Biological E's Corbevax gets WHO emergency use authorisation

IANS | January 16, 2024 3:50 PM

Hyderabad, Jan 16 (IANS) Biological E. Limited (BE), a Hyderabad-based vaccines and pharmaceutical company, on Tuesday announced that the World Health Organisation (WHO) has granted an Emergency Use Listing (EUL) to their Corbevax, which is India's first indigenously developed Covid-19 vaccine that is based on protein sub-unit platform.

Study finds new immune cell to attack and eliminate cancer, Covid

IANS | January 15, 2024 1:36 PM

New York, Jan 15 (IANS) Researchers have discovered a type of immune cell in the human body known to be important for allergy and other immune responses that can also attack and eliminate cancer and fight viruses like SARS-Cov-2, that causes Covid-19 infection.